Both in Pharmaceuticals
InMed Pharmaceuticals vs Apimeds Pharmaceuticals US
Over the past year INM returned −39.4% and APUS returned −73.6%; their daily moves had a correlation of 0.12.
INM −39.4% APUS −73.6%Growth of $1, one year, split-adjusted
| Metric | INM | APUS |
|---|---|---|
| Price | $1.38 | $5.02 |
| Market cap | $7.6M | $7.6M |
| Today | +1.10% | −21.44% |
| 1 month | −0.4% | +29.7% |
| 6 months | +123.6% | −71.3% |
| Year to date | +29.7% | −69.4% |
| 1 year | −37.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | — |
| Net cash | $2.2M | -$8.6M |
| Dividend yield | — | — |
| Volatility (60d) | 59.6% | 727.8% |
| Short % of float | 0.5% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).